Rasul Reazur 4

What Happened
Rasul Reazur, EVP and Group President, Healthcare at Baxter International, was granted 18,951 shares on Feb 9, 2026 as the final vesting of a 2023 performance share unit (PSU) award (acquisition price $0). To cover withholding taxes on the vesting, 5,770 shares were surrendered/forfeited (reported as a disposition) at $21.73 per share, for a tax-withholding value of $125,382. This was an award vesting event, not an open-market purchase or voluntary sale.

Key Details

• Transaction date: Feb 9, 2026; Form 4 filed Feb 11, 2026 (appears timely).
• Awarded/acquired: 18,951 shares at $0.00 (code A).
• Withheld/forfeited for taxes: 5,770 shares at $21.73, total $125,382 (code F).
• Shares owned after transaction: not disclosed in the provided filing.
• Footnotes:
  • F1: Shares are from the 2023 PSU award based on a 3-year performance period (Jan 1, 2023–Dec 31, 2025) tied to Sales CAGR, TSR, and ROIC; the performance period ended and these PSUs vested.
  • F2: The 5,770 shares represent shares forfeited to cover tax withholding on the vested PSUs.
  • F3: Totals include automatic reinvestment of dividends where applicable.

Context: This was a routine vesting of performance-based equity, with a portion of shares withheld to satisfy tax obligations (a common cashless withholding method). Because this was an award vesting and not an open-market sale or purchase, it should not be interpreted alone as a bullish or bearish signal about the stock.